Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of PF-08103402 in Healthy Adults and Adults With Mild to Moderate Asthma
NCT07660731Phase 1Recruiting
- Sponsor
- Pfizer
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Countries
- 2
01
Overview
Phase 1, randomised trial of PF-08103402 in asthma (6 arms), sponsored by Pfizer. Primary endpoints: Number of Participants with Treatment Emergent Adverse Events, Number of Participants with Serious Adverse Events and 6 more. Started Jun 2026; status: recruiting.
02
Drugs
PF-08103402
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07660731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07660731.